| 1 | Asthma, Aspirin-Induced | 28.3% |
| 2 | Dermatitis, Atopic | 26.7% |
| 3 | Contact Dermatitis | 26.7% |
| 4 | Eczema | 26.7% |
| 5 | Intertrigo | 26.7% |
| 6 | Neurodermatitis | 26.7% |
| 7 | Perioral Dermatitis | 26.7% |
| 8 | Dermatitis Herpetiformis | 25.8% |
| 9 | Dermatitis, Allergic Contact | 23.1% |
| 10 | Acrodermatitis | 22.2% |
| 11 | Gianotti-Crosti Syndrome | 22.2% |
| 12 | Dermatitis, Photoallergic | 21.5% |
| 13 | Dermatitis, Phototoxic | 20.2% |
| 14 | Phototoxicity | 20.2% |
| 15 | Pyoderma Gangrenosum | 20% |
| 16 | Dermatitis, Irritant | 19.7% |
| 17 | Dermatitis, Occupational | 17% |
| 18 | Mastocytosis | 16.8% |
| 19 | Lupus Erythematosus, Cutaneous | 16.4% |
| 20 | Panniculitis | 16.4% |
| 21 | Systemic Scleroderma | 16.4% |
| 22 | Morphea | 16.4% |
| 23 | Diaper Rash | 16.3% |
| 24 | Acne Vulgaris | 16% |
| 25 | Erythema Multiforme | 16% |
| 26 | Rhinophyma | 16% |
| 27 | Urticaria | 16% |
| 28 | Acne | 16% |
| 29 | Breast Diseases | 15.3% |
| 30 | Exanthema | 15.3% |
| 31 | Facial Dermatoses | 15.3% |
| 32 | Hair Diseases | 15.3% |
| 33 | Hand Dermatoses | 15.3% |
| 34 | Immune Complex Diseases | 15.3% |
| 35 | keratoacanthoma | 15.3% |
| 36 | Keratosis | 15.3% |
| 37 | Nail Diseases | 15.3% |
| 38 | Photosensitivity Disorders | 15.3% |
| 39 | Prurigo | 15.3% |
| 40 | Pyoderma | 15.3% |
| 41 | Rosacea | 15.3% |
| 42 | Sebaceous Gland Diseases | 15.3% |
| 43 | Skin Diseases, Vesiculobullous | 15.3% |
| 44 | Skin Ulcer | 15.3% |
| 45 | Sweat Gland Diseases | 15.3% |
| 46 | Anticholinergic Syndrome | 15.3% |
| 47 | Skin Diseases, Papulosquamous | 15.3% |
| 48 | Skin Diseases, Vascular | 15.3% |
| 49 | Acneiform Eruptions | 15.3% |
| 50 | Ocular Rosacea | 15.3% |
| 51 | Latex allergy | 15.3% |
| 52 | Subcorneal pustular dermatosis | 15.3% |
| 53 | Serotonin Syndrome | 15.3% |
| 54 | Propofol Infusion Syndrome | 15.3% |
| 55 | Erythematotelangiectatic Rosacea | 15.3% |
| 56 | Papulopustular Rosacea | 15.3% |
| 57 | Chronic Actinic Dermatitis | 15.3% |
| 58 | Epidermolysis Bullosa | 15% |
| 59 | Pityriasis Lichenoides et Varioliformis Acuta | 14.8% |
| 60 | Pityriasis Lichenoides | 14.8% |
| 61 | Xeroderma Pigmentosum | 14.6% |
| 62 | Foot Ulcer | 13.9% |
| 63 | Chemical and Drug Induced Liver Injury | 13.8% |
| 64 | Sebaceous Gland Neoplasms | 13.3% |
| 65 | Porokeratosis | 13.3% |
| 66 | Keratoderma, Palmoplantar | 13.3% |
| 67 | Panniculitis, Lupus Erythematosus | 13.2% |
| 68 | Necrobiosis Lipoidica Diabeticorum | 12.8% |
| 69 | Foot Diseases | 12.7% |
| 70 | Environmental Illness | 12.7% |
| 71 | Skin Abnormalities | 12.3% |
| 72 | Skin Diseases, Infectious | 12.3% |
| 73 | Skin Neoplasms | 12.3% |
| 74 | Pigmentation Disorders | 12.3% |
| 75 | Metabolic Side Effects of Drugs and Substances | 12.3% |
| 76 | Lipomatosis | 12.2% |
| 77 | Pemphigus | 12.2% |
| 78 | Pruritus | 12.2% |
| 79 | Erythema | 12.2% |
| 80 | Injection Site Reaction | 12.2% |
| 81 | Necrolytic Migratory Erythema | 12.2% |
| 82 | Cutaneous Fistula | 12.2% |
| 83 | Infusion site reaction | 12.2% |
| 84 | Nephrogenic Fibrosing Dermopathy | 12.2% |
| 85 | Nephrogenic Systemic Fibrosis | 12.2% |
| 86 | Acne Conglobata | 11.8% |
| 87 | Erythema Induratum | 11.6% |
| 88 | Xeroderma | 11.5% |
| 89 | Dermatomyositis | 11.5% |
| 90 | Urticaria Pigmentosa | 11.5% |
| 91 | Argyria | 10.7% |
| 92 | Lupus Erythematosus, Discoid | 10.7% |
| 93 | Scleroderma, Limited | 10.7% |
| 94 | Cutis Laxa | 10.1% |
| 95 | Kounis Syndrome | 10.1% |
| 96 | Erythema Infectiosum | 10% |
| 97 | Pseudoxanthoma Elasticum | 10% |
| 98 | anaphylaxis | 10% |
| 99 | Angioedema | 10% |
| 100 | Anhidrosis | 10% |
| 101 | Cholesteatoma | 10% |
| 102 | Pressure Ulcer | 10% |
| 103 | Ectodermal Dysplasia | 10% |
| 104 | Exanthema Subitum | 10% |
| 105 | Folliculitis | 10% |
| 106 | Food Allergy | 10% |
| 107 | Foot Dermatoses | 10% |
| 108 | Gynecomastia | 10% |
| 109 | Hypertrichosis | 10% |
| 110 | Hypohidrosis | 10% |
| 111 | Hypotrichosis | 10% |
| 112 | Leg Ulcer | 10% |
| 113 | Miliaria | 10% |
| 114 | Parakeratosis | 10% |
| 115 | Parapsoriasis | 10% |
| 116 | Pityriasis | 10% |
| 117 | Psoriasis | 10% |
| 118 | Sweet Syndrome | 10% |
| 119 | Hidradenitis | 10% |
| 120 | Onycholysis | 10% |
| 121 | Miliaria Rubra | 10% |
| 122 | Hyperpigmentation | 10% |
| 123 | Lichenoid Eruptions | 10% |
| 124 | Chloracne | 10% |
| 125 | Aplasia Cutis Congenita | 10% |
| 126 | Anaphylactic shock | 10% |
| 127 | Papillon-Lefevre Disease | 9.8% |
| 128 | Akathisia, Drug-Induced | 9.3% |
| 129 | Tinea Capitis | 9.1% |
| 130 | Onychomycosis | 9.1% |
| 131 | Chemical and Drug Induced Liver Injury, Chronic | 8.9% |
| 132 | Cardiotoxicity | 8.8% |
| 133 | Autoimmune Diseases | 8.8% |
| 134 | Connective Tissue Diseases | 8.8% |
| 135 | Immunologic Deficiency Syndromes | 8.8% |
| 136 | Immunoproliferative Disorders | 8.8% |
| 137 | Poisoning | 8.8% |
| 138 | Immune reconstitution syndrome | 8.8% |
| 139 | Immune Reconstitution Inflammatory Syndrome | 8.8% |
| 140 | Hyperkeratosis, Epidermolytic | 8.6% |
| 141 | Ecthyma | 8.6% |
| 142 | Respiratory Hypersensitivity | 8.3% |
| 143 | Granuloma Annulare | 8.3% |
| 144 | Lupus Erythematosus, Systemic | 8.2% |
| 145 | Ichthyosis, X-Linked | 8.2% |
| 146 | Overlap syndrome | 8.2% |
| 147 | Dyskinesia, Drug-Induced | 8.2% |
| 148 | Sjogren-Larsson Syndrome | 8.2% |
| 149 | Acantholysis | 8.1% |
| 150 | Breast Cyst | 8.1% |
| 151 | Actinic keratosis | 8.1% |
| 152 | Pemphigoid, Benign Mucous Membrane | 8.1% |
| 153 | Piedra | 8.1% |
| 154 | Sick Building Syndrome | 8.1% |
| 155 | Sunburn | 8.1% |
| 156 | Multiple Chemical Sensitivity | 8.1% |
| 157 | Hirsutism | 8% |
| 158 | Lactation Disorder | 8% |
| 159 | Mastitis | 8% |
| 160 | Vasculitis, Leukocytoclastic, Cutaneous | 8% |
| 161 | Adiposis Dolorosa | 7.9% |
| 162 | Pruritus Vulvae | 7.9% |
| 163 | Mastocytoma | 7.9% |
| 164 | Pruritus Ani | 7.9% |
| 165 | Behcet Syndrome | 7.8% |
| 166 | Lichen Planus | 7.4% |
| 167 | Melanosis | 7.4% |
| 168 | Chloasma | 7.4% |
| 169 | Pityriasis Rosea | 7.4% |
| 170 | Pityriasis Rubra Pilaris | 7.4% |
| 171 | Vitiligo | 7.4% |
| 172 | Milk Allergy | 7.4% |
| 173 | Lichen Nitidus | 7.4% |
| 174 | Wheat Hypersensitivity | 7.4% |
| 175 | Hidradenitis Suppurativa | 7.4% |
| 176 | Hereditary Angioedema Type III | 7.3% |
| 177 | Hereditary Angioedema Types I and II | 7.3% |
| 178 | Drug abuse | 7.2% |
| 179 | Substance Dependence | 7.2% |
| 180 | Substance-Related Disorders | 7.2% |
| 181 | Drug Dependence | 7.2% |
| 182 | Angioedemas, Hereditary | 7.1% |
| 183 | Transfusion Reaction | 7% |
| 184 | Hypotensive Transfusion Reaction | 7% |
| 185 | Albinism | 7% |
| 186 | Erythema Chronicum Migrans | 6.9% |
| 187 | Dermatomycoses | 6.7% |
| 188 | Mucocutaneous Lymph Node Syndrome | 6.7% |
| 189 | Skin Diseases, Bacterial | 6.7% |
| 190 | Tinea Pedis | 6.7% |
| 191 | Lipodystrophy | 6.7% |
| 192 | Livedo Reticularis | 6.7% |
| 193 | Malignant Atrophic Papulosis | 6.7% |
| 194 | Polyarteritis Nodosa | 6.6% |
| 195 | Takayasu Arteritis | 6.6% |
| 196 | Toxic Epidermal Necrolysis | 6.5% |
| 197 | Stevens-Johnson Syndrome | 6.5% |
| 198 | Acanthosis Nigricans | 6.2% |
| 199 | Alopecia Areata | 6.2% |
| 200 | Lentigo | 6.2% |
| 201 | Alopecia | 6% |
| 202 | Sweating, Gustatory | 6% |
| 203 | Androgenetic Alopecia | 6% |
| 204 | Auriculotemporal Syndrome | 6% |
| 205 | Lice Infestations | 6% |
| 206 | Varicose Ulcer | 6% |
| 207 | Breast Neoplasms, Male | 6% |
| 208 | Triple Negative Breast Neoplasms | 6% |
| 209 | Galactorrhea | 5.9% |
| 210 | Mastocytosis, Systemic | 5.9% |
| 211 | Mycetoma | 5.9% |
| 212 | Psychoses, Substance-Induced | 5.9% |
| 213 | Nail-Patella Syndrome | 5.8% |
| 214 | Porphyrias, Hepatic | 5.8% |
| 215 | Glomerulonephritis, Membranoproliferative | 5.6% |
| 216 | Erythema Nodosum | 5.6% |
| 217 | Serum Sickness | 5.6% |
| 218 | Mushroom Poisoning | 5.3% |
| 219 | Collagen Diseases | 5.1% |
| 220 | Fluoride Poisoning | 5.1% |
| 221 | Food Poisoning | 5.1% |
| 222 | Gas Poisoning | 5.1% |
| 223 | Mixed Connective Tissue Disease | 5.1% |
| 224 | Mycotoxicosis | 5.1% |
| 225 | Plant Poisoning | 5.1% |
| 226 | Antiphospholipid Syndrome | 5.1% |
| 227 | Mucinoses | 5.1% |
| 228 | Organophosphate poisoning | 5.1% |
| 229 | Larva Migrans | 5% |
| 230 | Leishmaniasis | 5% |
| 231 | Molluscum Contagiosum | 5% |
| 232 | Lichen Planus, Oral | 5% |
| 233 | Onchocerciasis | 5% |
| 234 | Chromoblastomycosis | 4.9% |
| 235 | Dermatophytosis | 4.9% |
| 236 | Sporotrichosis | 4.9% |
| 237 | Tinea | 4.9% |
| 238 | Tinea Versicolor | 4.9% |
| 239 | Trichophytosis | 4.9% |
| 240 | Hyalohyphomycosis | 4.9% |
| 241 | Giant Cell Arteritis | 4.9% |
| 242 | Temporal Arteritis | 4.9% |
| 243 | Rheumatoid Arthritis | 4.9% |
| 244 | Autoimmune Lymphoproliferative Syndrome | 4.9% |
| 245 | Juvenile arthritis | 4.9% |
| 246 | HIV-Associated Lipodystrophy Syndrome | 4.7% |
| 247 | CREST Syndrome | 4.4% |
| 248 | Asthma | 4.3% |
| 249 | Warts | 4.3% |
| 250 | Candidiasis, Chronic Mucocutaneous | 4.2% |
| 251 | Cutaneous Candidiasis | 4.2% |
| 252 | Bites and Stings | 4.2% |
| 253 | Cartilage Diseases | 4.2% |
| 254 | Erysipelas | 4.2% |
| 255 | Rheumatism | 4.2% |
| 256 | Staphylococcal Skin Infections | 4.2% |
| 257 | Chondromalacia | 4.2% |
| 258 | Variegate Porphyria | 4.2% |
| 259 | Acute intermittent porphyria | 4.2% |
| 260 | Porphyria Cutanea Tarda | 4.2% |
| 261 | Neurotoxicity Syndromes | 4.2% |
| 262 | Erythrasma | 4.2% |
| 263 | Carcinoma, Lobular | 4.2% |
| 264 | Arthritis, Psoriatic | 4.2% |
| 265 | Thrombocytopenic purpura | 4.2% |
| 266 | Asthma, Exercise-Induced | 4.1% |
| 267 | Status Asthmaticus | 4.1% |
| 268 | Leishmaniasis, Cutaneous | 4.1% |
| 269 | Lymphoproliferative Disorders | 4.1% |
| 270 | Marijuana Abuse | 4.1% |
| 271 | Opioid-Related Disorders | 4.1% |
| 272 | Nicotine Dependence | 4.1% |
| 273 | Opioid abuse | 4.1% |
| 274 | Phencyclidine Abuse | 4.1% |
| 275 | Substance Abuse, Intravenous | 4.1% |
| 276 | Substance Withdrawal Syndrome | 4.1% |
| 277 | Tobacco Use Disorder | 4.1% |
| 278 | Alcohol-Related Disorders | 4.1% |
| 279 | Amphetamine-Related Disorders | 4.1% |
| 280 | Cocaine-Related Disorders | 4.1% |
| 281 | Eczema Herpeticum | 4.1% |
| 282 | Fusariosis | 4.1% |
| 283 | Addison Disease | 4.1% |
| 284 | Paraproteinemias | 4.1% |
| 285 | Water Intoxication | 4.1% |
| 286 | Arsenic Poisoning | 4.1% |
| 287 | Autoimmune thyroiditis | 4.1% |
| 288 | Primary Adrenal Insufficiency | 4.1% |
| 289 | Lymphopenia | 4% |
| 290 | Drug Overdose | 4% |
| 291 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 4% |
| 292 | Autoimmune hepatitis | 4% |
| 293 | Autoimmune thrombocytopenia | 4% |
| 294 | Immune thrombocytopenic purpura | 4% |
| 295 | Alcohol-Induced Disorders, Nervous System | 3.9% |
| 296 | Primary amyloidosis | 3.8% |
| 297 | Monoclonal Gammopathy of Undetermined Significance | 3.8% |
| 298 | Lupus Nephritis | 3.8% |
| 299 | Aspergillosis, Allergic Bronchopulmonary | 3.7% |
| 300 | Asthma, Occupational | 3.6% |
| 301 | Farmer's Lung | 3.6% |
| 302 | Epidermodysplasia Verruciformis | 3.5% |
| 303 | Herpes Labialis | 3.5% |
| 304 | Hay fever | 3.5% |
| 305 | Rhinitis, Allergic, Perennial | 3.5% |
| 306 | Diabetic Foot | 3.5% |
| 307 | Alcohol Withdrawal Delirium | 3.5% |
| 308 | Staphylococcal Scalded Skin Syndrome | 3.5% |
| 309 | Alcohol Withdrawal Seizures | 3.5% |
| 310 | Neonatal Abstinence Syndrome | 3.4% |
| 311 | Hypergammaglobulinemia | 3.4% |
| 312 | Latent Autoimmune Diabetes in Adults | 3.4% |
| 313 | Agammaglobulinemia | 3.4% |
| 314 | HIV Infections | 3.4% |
| 315 | Transfusion-Related Acute Lung Injury | 3.4% |
| 316 | Dupuytren Contracture | 3.3% |
| 317 | Cadmium poisoning | 3.3% |
| 318 | Carbon Monoxide Poisoning | 3.3% |
| 319 | Ciguatera Poisoning | 3.3% |
| 320 | Ergotism | 3.3% |
| 321 | Lead Poisoning | 3.3% |
| 322 | Mercury Poisoning | 3.3% |
| 323 | Alcohol-Induced Disorders | 3.3% |
| 324 | Scleromyxedema | 3.3% |
| 325 | Shellfish Poisoning | 3.3% |
| 326 | Blastomycosis | 3.3% |
| 327 | Felty Syndrome | 3.3% |
| 328 | Psychoses, Alcoholic | 3.3% |
| 329 | Peutz-Jeghers Syndrome | 3.2% |
| 330 | carbuncle | 3.1% |
| 331 | Condylomata Acuminata | 3.1% |
| 332 | Furunculosis | 3.1% |
| 333 | furuncle | 3.1% |
| 334 | Impetigo | 3% |
| 335 | Rhinoscleroma | 3% |
| 336 | Menkes Kinky Hair Syndrome | 3% |
| 337 | Multiple Myeloma | 2.9% |
| 338 | Graves Disease | 2.9% |
| 339 | Rheumatoid Vasculitis | 2.9% |
| 340 | Cellulitis | 2.9% |
| 341 | Anti-Glomerular Basement Membrane Disease | 2.8% |
| 342 | Insect Bites and Stings | 2.7% |
| 343 | Mesenteric Panniculitis | 2.7% |
| 344 | Panniculitis, Peritoneal | 2.7% |
| 345 | Tietze's Syndrome | 2.7% |
| 346 | Orbital Cellulitis | 2.7% |
| 347 | Myxoid cyst | 2.7% |
| 348 | Alcohol Use Disorder | 2.7% |
| 349 | Alcoholic Intoxication | 2.7% |
| 350 | Heroin Dependence | 2.7% |
| 351 | Morphine Dependence | 2.7% |
| 352 | Myxedema | 2.7% |
| 353 | Plasmacytoma | 2.7% |
| 354 | Tumor Lysis Syndrome | 2.7% |
| 355 | Alcohol abuse | 2.7% |
| 356 | Manganese Poisoning | 2.7% |
| 357 | HTLV-I Infections | 2.6% |
| 358 | Job Syndrome | 2.6% |
| 359 | Salmonella food poisoning | 2.6% |
| 360 | Sicca Syndrome | 2.6% |
| 361 | Sjogren's Syndrome | 2.6% |
| 362 | Lupus Vasculitis, Central Nervous System | 2.6% |
| 363 | Sezary Syndrome | 2.5% |
| 364 | Schnitzler Syndrome | 2.5% |
| 365 | Osteochondritis | 2.3% |
| 366 | Polymyalgia Rheumatica | 2.3% |
| 367 | Lymphoma | 2.2% |
| 368 | Myasthenia Gravis | 2.2% |
| 369 | Uveomeningoencephalitic Syndrome | 2.2% |
| 370 | Neuroleptic Malignant Syndrome | 2.2% |
| 371 | Osteogenesis Imperfecta | 2.2% |
| 372 | Kernicterus | 2.2% |
| 373 | Noonan Syndrome | 2.2% |
| 374 | Chronic granulomatous disease | 2.2% |
| 375 | Heavy Chain Disease | 2.2% |
| 376 | Binge Drinking | 2.2% |
| 377 | Granulomatosis with polyangiitis | 2.2% |
| 378 | Keloid | 2.2% |
| 379 | HIV Seropositivity | 2.2% |
| 380 | Myasthenia Gravis, Autoimmune, Experimental | 2.2% |
| 381 | Tick Paralysis | 2.1% |
| 382 | Marfan Syndrome | 2% |
| 383 | Ataxia Telangiectasia | 2% |
| 384 | Cardiomyopathy, Alcoholic | 2% |
| 385 | Hydrops Fetalis | 2% |
| 386 | Pancreatitis, Alcoholic | 2% |
| 387 | Mercury Poisoning, Nervous System | 2% |
| 388 | Lead Poisoning, Nervous System | 2% |
| 389 | Homocystinuria | 2% |
| 390 | Stiff-Person Syndrome | 1.9% |
| 391 | Polyradiculoneuropathy | 1.9% |
| 392 | Polyradiculoneuritis | 1.9% |
| 393 | Botulism | 1.9% |
| 394 | Acquired Immunodeficiency Syndrome | 1.9% |
| 395 | AIDS related complex | 1.9% |
| 396 | Infectious Mononucleosis | 1.9% |
| 397 | MPTP Poisoning | 1.9% |
| 398 | Cryoglobulinemia | 1.9% |
| 399 | POEMS Syndrome | 1.9% |
| 400 | Laryngomalacia | 1.7% |
| 401 | Pectus carinatum | 1.7% |
| 402 | AIDS-Related Opportunistic Infections | 1.7% |
| 403 | Fetal Alcohol Spectrum Disorders | 1.7% |
| 404 | Vasculitis, Central Nervous System | 1.7% |
| 405 | Multiple Sclerosis | 1.7% |
| 406 | HIV Wasting Syndrome | 1.6% |
| 407 | Hodgkin Disease | 1.6% |
| 408 | Leukemia, Plasma Cell | 1.6% |
| 409 | Lymphoma, Non-Hodgkin | 1.6% |
| 410 | Rheumatoid Nodule | 1.6% |
| 411 | Wernicke Encephalopathy | 1.6% |
| 412 | AIDS Dementia Complex | 1.6% |
| 413 | AIDS-Associated Nephropathy | 1.6% |
| 414 | Leukemia, T-Cell | 1.6% |
| 415 | Neuromyelitis Optica | 1.6% |
| 416 | Lead Poisoning, Nervous System, Childhood | 1.6% |
| 417 | Lead Poisoning, Nervous System, Adult | 1.6% |
| 418 | Leukemia, B-Cell | 1.6% |
| 419 | Leukoencephalitis, Acute Hemorrhagic | 1.6% |
| 420 | Lambert-Eaton Myasthenic Syndrome | 1.5% |
| 421 | Waldenstrom Macroglobulinemia | 1.5% |
| 422 | Wiskott-Aldrich Syndrome | 1.5% |
| 423 | Bronchomalacia | 1.4% |
| 424 | Composite Lymphoma | 1.4% |
| 425 | Tracheomalacia | 1.4% |
| 426 | Encephalomyelitis, Acute Disseminated | 1.4% |
| 427 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1.4% |
| 428 | Neuritis, Autoimmune, Experimental | 1.4% |
| 429 | Lymphangioleiomyomatosis | 1.4% |
| 430 | Fatty Liver, Alcoholic | 1.4% |
| 431 | Hepatitis, Alcoholic | 1.4% |
| 432 | Liver Cirrhosis, Alcoholic | 1.4% |
| 433 | Acrodynia | 1.4% |
| 434 | Multiple Sclerosis, Chronic Progressive | 1.4% |
| 435 | Multiple Sclerosis, Relapsing-Remitting | 1.4% |
| 436 | Lymphoma, Follicular | 1.4% |
| 437 | T-Cell Lymphoma | 1.4% |
| 438 | Mantle cell lymphoma | 1.4% |
| 439 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 440 | Leukemia, Large Granular Lymphocytic | 1.4% |
| 441 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 442 | Guillain-Barre Syndrome | 1.2% |
| 443 | Lymphoma, T-Cell, Cutaneous | 1.2% |
| 444 | Lymphoma, AIDS-Related | 1.2% |
| 445 | Enteropathy-Associated T-Cell Lymphoma | 1.2% |
| 446 | Primary Effusion Lymphoma | 1.2% |
| 447 | Mucopolysaccharidosis III | 1.2% |
| 448 | Mycosis Fungoides | 1.1% |
| 449 | Lymphomatoid Papulosis | 1.1% |
| 450 | Plasmablastic lymphoma | 1.1% |
| 451 | Lymphomatoid Granulomatosis | 1.1% |
| 452 | Burkitt Lymphoma | 0.9% |
| 453 | Myelitis, Transverse | 0.9% |
| 454 | Mucopolysaccharidosis II | 0.9% |
| 455 | Miller Fisher Syndrome | 0.7% |
